Oral corticosteroids can improve nocturnal isolated hypoxemia in stable COPD patients with diurnal PaO2 > 60 mmHg

European Review for Medical and Pharmacological Sciences

Volumn 11, Issue 6, 2007, Pages 365-372

  Sposato, B ^a   Mariotta, S ^b   Palmiero, G ^a   Ricci, A ^b   Gencarelli, G ^b   Franco, C ^a  

^a MISERICORDIA HOSPITAL   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

COPD; Corticosteroid; Nocturnal SpO2; Pulso oxymetry

Indexed keywords

ACETYLCYSTEINE; BAMIFYLLINE; BECLOMETASONE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; BUDESONIDE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; FLUTICASONE; FORMOTEROL; IPRATROPIUM BROMIDE; METHYLPREDNISOLONE; MUCOLYTIC AGENT; OXITROPIUM BROMIDE; OXYHEMOGLOBIN; SALBUTAMOL; SALMETEROL; THEOPHYLLINE; THEOPHYLLINE DERIVATIVE; TIOTROPIUM BROMIDE;

ADULT; AGED; APNEA; ARTERIAL OXYGEN TENSION; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; DRUG DOSE REDUCTION; DYSPNEA; FEMALE; FORCED EXPIRATORY VOLUME; HEART RATE; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPOXEMIA; INSPIRATORY CAPACITY; LUNG FUNCTION; MALE; OXYGEN SATURATION; POLYSOMNOGRAPHY; PULSE OXIMETRY; RANDOMIZED CONTROLLED TRIAL; SHORT COURSE THERAPY; SLEEP TIME; STEROID THERAPY; TREATMENT DURATION;

AGED; AGED, 80 AND OVER; ANOXIA; BRONCHODILATOR AGENTS; DRUG THERAPY, COMBINATION; FEMALE; GLUCOCORTICOIDS; HUMANS; MALE; METHYLPREDNISOLONE; MIDDLE AGED; OXIMETRY; OXYGEN; OXYHEMOGLOBINS; PARTIAL PRESSURE; POLYSOMNOGRAPHY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY FUNCTION TESTS; SLEEP;

EID: 39049166132     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. FLETCHER EC, MILLER J, DIVINE GW, FLETCHER JC, MILLER T. Nocturnal oxyhemoglobin desaturation in COPD patients with arterial oxygen tensions above 60 mmHg. Chest 1987; 92: 604-608.
2. DOUGLAS NJ. Sleep in patients with chronic obstructive pulmonary disease. Clin Chest Med 1998; 19: 115-125.
3. MCNICHOLAS WT. Impact of sleep in COPD. Chest 2000; 117: 48S-53S.
4. DE ANGELIS G, SPOSATO B, MAZZEI L, GIOCONDI F, SBROCCA A, PROPATI A, GENTILE J. Predictive indexes of nocturnal desaturation in COPD patients not treated with long term oxygen therapy. Eur Rev Med Pharmacol Sci 2001; 5:173-179.
5. TURATO G, ZUIN R, MINIATI M, BARALDO S, REA F, BEGHE B, MONTI S, FORMICHI B, BOSCHETTO P HARARI S, PAPI A, MAESTRELLI P, FABBRI LM, Saetta M. Airway inflammation in severe chronic obstructive pulmonary disease: Relationship with lung function and radiologic emphysema. Am J Respir Crit Care Med 2002; 166: 105-110.
6. HOGG JC, CHU F, UTOPARCH S, WOODS R, ELLIOT WM, BUZATU L, CHERNIACK RM, ROGERS RM, SCIURBA FC, COXSON HO, PARE PD. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 2004; 350: 2645-2653.
7. FUJIMOTO K, YASUO M, URUSHIBATA K, HANAOKA M, KOIZUMI T, KUBO K. Airway inflammation during stable and acutely exacerbated chronic obstructive pulmonary disease. Eur Respir J 2005; 25: 640-646.
8. SOLER N, EWIG S, TORRES A, FILELLA X, GONZALEZ J, ZAUBET A. Airway inflammation and bronchial microbial patterns in patients with stable chronic obstructive pulmonary disease. Eur Respir J 1999; 14: 1015-1022.
9. POSTMA DS, KEYZER JJ, KOETER GH, SLUITER HJ, DE VRIES K. Influence of the parasympathetic nervous system on nocturnal bronchial obstruction. Clin Sci 1985; 69: 251-258.
10. MCNICHOLAS WT, CALVERLEY PMA, LEE A, EDWARDS JC. Long-acting inhaled anticholinergic therapy improves sleeping oxygen saturation in COPD. Eur Respir J 2004; 23: 825-831.
11. MARTIN RJ, BARTELSON BL, SMITH P, HUDGEL DW, LEWIS D, POHL G, KOKER P, SOUHRADA JF. Effect of ipratropium bromide treatment on oxygen saturation and sleep quality in COPD. Chest 1999; 115: 1525-1532.
12. WALTERS J, WALTERS E, WOOD-BAKER R. Oral corticosteroids for stable chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2005 Jul 20; (3): CD005374.
13. DAVIES L, NISAR M, PEARSON MG, COSTELLO RW, EARIS JE, CALVERLEY PM. Oral corticosteroid Trials in the management of stable chronic obstructive pulmonary disease. QJM 1999; 92: 395-400.
14. CONFALONIERI M, MAINARDI E, DELLA PORTA R, BERNORIO S, GANDOLA L, BEGHE B, SPANEVELLO A. Inhaled corticosteroid reduce neutrophilic bronchial inflammation in patients with chronic obstructive pulmonary disease. Thorax 1998; 53: 583-585.
15. BALBI B, MAJORI M, BERTACCO S CONVERTINO G, CUOMO A DONNER CF, PESCI A. Inhaled corticosteroids in stable COPD patients: Do they have effects on cells and molecular mediators of airway inflammation? Chest 2000; 117: 1633-1637.
16. BARCZYC A, SOZANSKA E, TRZASKA M, PIERZCHAIA W. Decreased levels of myeloperoxidase in induced sputum of patients with COPD after treatment with oral glucocorticoids. Chest 2004; 126: 389-393.
17. GLOBAL INITLATIVE FOR CHRONIC OBSTRUCTIVE LUNG DISEASE. Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease. NHLBI/WHO workshop report 2005; www.goldcopd.com.
18. CALLAHAN CM, DITTUS RS, KATZ BP. Oral corticosteroid therapy for patients with stable chronic obstructive pulmonary disease. A meta-analysis. Ann Intern Med 1991; 114: 216-223.
19. QUANJER PH, TAMMELING GJ, COTES FE, PEDERSEN OF, PESLIN R, YERNAULT JC. Standardized lung function testing. Eur Respir J 1993; 6(Suppl 16): 1-99.
20. KRACHMAN SL, CHATILA W, MARTIN UJ, NUGENT T, CROCETTI J, GAUGHAN J, CRINER GJ. Effects of lung volume reduction surgery on sleep quality and nocturnal gas exchange in patients with severe emphysema. Chest 2005; 128: 3221-3228.
21. MULLOY E, MCNICHOLAS W. Theophylline improves gas exchange during rest, exercise and sleep in severe chronic pulmonary disease. Am Rev Respir Dis 1993; 148: 1030-1036.
22. GC MAN, CHAMPMAN KR, ALI SH, DARKE AC. Sleep quality and nocturnal respiratory function with once-daily theophylline (Uniphyl) and inhaled salbutamol in patients with COPD. Chest 1996; 110: 648-653.
23. MULLOY E, MCNICHOLAS WT. Ventilation and gas exchange during sleep and exercise in severe COPD. Chest 1996; 109: 387-394.
24. SIAFAKAS NM, VERMEIRE P, PRIDE NB, PAOLETTI P, GIBSON J, HOWARD P, YERNAULT JC, DECRAMER M, HIGENBOTTAM T, POSTMA DS, REES J. Optimal assessment and management of chronic obstructive pulmonary disease (COPID). Eur Respir J 1995; 8: 1398-1420.
25. BARTELS MN, GONZALEZ JM, KIM W, DE MEERSMAN RE. Oxygen supplementation and cardiac-autonomic modulation in COPD. Chest 2000; 118: 691-696.
26. TRAKADA G, MARANGOS M, SPIROPOULOS K. Mechanisms of endothelin-1 elevation in chronic obstructive pulmonary disease patients with nocturnal oxyhemoglobin clesaturation. Respiration 2001; 68: 134-139.
27. DSCHIETZIG T, RICHTER C, PFANNENSHMIDT G, BARTSCH C, LAULE M, BAUMANN G, STANGL K. Dexamethasone inhibits stimulation of pulmonary endothelins by proinflammatory cytokines: Possible involvement of a nuclear factor kappaB dependent mechanism. Intensive Care Med 2001; 27: 751-756.
28. PEARL JM, SCHWARTZ SM, NELSON DP, WAGNER CJ, LYONS JM, BAUER SM, DUFFY JY. Preoperative glucocorticoids decrease pulmonary hipertension in piglets after cardiopulmonary bypass and circulatory arrest. Ann Thorac Surg 2004; 77: 994-1000.
29. CALVERLEY PMA, LEE A, TOWSE L, VAN NOORD J, WITEK TJ, KELSEN S. Effect of tiotropium bromide on circadian variation in airflow limitation in chronic obstructive pulmonary disease. Thorax 2003; 58: 855-860.